Journals over the past year, will be discussed by HEPATOLOGY Associate Editors Jacqueline O'Leary, Cynthia Levy and Sumera Ilyas. Then, Editor-in-Chief Gregory Gores and Associate Editor Juan Abraldes will host a panel discussion that highlights the clini

(1 of 2 identical workshops offered during TLM 2023)

Individuals with Hepatitis C virus are curable if they follow a simplified treatment algorithm of highly effective, short-duration direct-acting antiviral therapy. Nevertheless, less than half of people living with hepatitis C have been diagnosed and only

The goal of this session is to review current innovations in transplantation and what is being developed for use in the near future. The session will focus on the innovations in artificial organs and xenotransplantation, future policy changes in organ all

Part 2: Multidisciplinary and Critical Care Management of ACLF

Part 1

To meet the WHO's goal of eliminating chronic hepatitis B by 2030, healthcare professionals, such as general practitioners and allied health professionals, must optimize the cascade of diagnosis and care. They play a key role in expanding treatment criter

Breakout D: Rare Diseases (Pediatric + Others)

The integration of artificial intelligence (AI) into diagnosis and treatment of liver disease is a widely discussed topic of relevance for clinical trials and future drug development. Attendees will learn a basic understanding of AI approaches in liver di